These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24573199)

  • 1. Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer.
    Minami S; Nagashio R; Ueda J; Matsumoto K; Goshima N; Hattori M; Hachimura K; Iwamura M; Sato Y
    Biomed Res; 2014; 35(1):25-35. PubMed ID: 24573199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.
    Minami S; Matsumoto K; Nagashio R; Hagiuda D; Fukuda E; Goshima N; Hattori M; Tsuchiya B; Hachimura K; Jiang SX; Saegusa M; Iwamura M; Sato Y
    Anticancer Res; 2017 Dec; 37(12):6705-6714. PubMed ID: 29187447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
    Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
    Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calreticulin is a B cell molecular target in some gastrointestinal malignancies.
    Pekáriková A; Sánchez D; Palová-Jelínková L; Simsová M; Benes Z; Hoffmanová I; Drastich P; Janatková I; Mothes T; Tlaskalová-Hogenová H; Tucková L
    Clin Exp Immunol; 2010 May; 160(2):215-22. PubMed ID: 20030668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody biomarkers for the detection of serous ovarian cancer.
    Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
    Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.
    Taylor DD; Gercel-Taylor C; Parker LP
    Gynecol Oncol; 2009 Oct; 115(1):112-120. PubMed ID: 19647308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
    Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
    Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.
    Grassadonia A; Tinari N; Natoli C; Yahalom G; Iacobelli S
    Dis Markers; 2013; 35(6):747-52. PubMed ID: 24347795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
    Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
    Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.
    Kobayashi M; Nagashio R; Ryuge S; Murakami Y; Yanagita K; Nakashima H; Matsumoto T; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
    Biomed Res; 2014; 35(2):133-43. PubMed ID: 24759181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
    Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
    J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma.
    Yanagita K; Nagashio R; Ryuge S; Katono K; Jiang SX; Tsuchiya B; Nakashima H; Fukuda E; Goshima N; Saegusa M; Satoh Y; Masuda N; Sato Y
    Asian Pac J Cancer Prev; 2015; 16(17):7959-65. PubMed ID: 26625826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.